Lamin A and Prelamin A Counteract Migration of Osteosarcoma Cells.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
22 03 2020
Historique:
received: 03 01 2020
revised: 16 03 2020
accepted: 19 03 2020
entrez: 3 4 2020
pubmed: 3 4 2020
medline: 11 2 2021
Statut: epublish

Résumé

A type lamins are fundamental components of the nuclear lamina. Changes in lamin A expression correlate with malignant transformation in several cancers. However, the role of lamin A has not been explored in osteosarcoma (OS). Here, we wanted to investigate the role of lamin A in normal osteoblasts (OBs) and OS cells. Thus, we studied the expression of lamin A/C in OS cells compared to OBs and evaluated the effects of lamin A overexpression in OS cell lines. We show that, while lamin A expression increases during osteoblast differentiation, all examined OS cell lines express lower lamin A levels relative to differentiated OBs. The condition of low

Identifiants

pubmed: 32235738
pii: cells9030774
doi: 10.3390/cells9030774
pmc: PMC7140691
pii:
doi:

Substances chimiques

Lamin Type A 0
prelamin A 0
Lovastatin 9LHU78OQFD

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Sarcoma. 2012;2012:627254
pubmed: 22685381
Oncol Rep. 2017 Mar;37(3):1387-1393
pubmed: 28112365
Pathol Res Pract. 2015 Feb;211(2):175-82
pubmed: 25499720
J Cell Biol. 2014 Mar 3;204(5):669-82
pubmed: 24567359
Clin Exp Metastasis. 2005;22(4):319-29
pubmed: 16170668
Adv Biol Regul. 2019 Jan;71:1-9
pubmed: 30420274
Genes Dev. 2015 Feb 1;29(3):225-37
pubmed: 25644599
Science. 2001 May 11;292(5519):1160-4
pubmed: 11349148
J Physiol Biochem. 2019 Feb;75(1):11-18
pubmed: 30706289
J Exp Clin Cancer Res. 2009 Jan 15;28:8
pubmed: 19144202
J Bone Miner Res. 2009 Jan;24(1):78-86
pubmed: 18767923
Med Res Rev. 2010 Jan;30(1):102-35
pubmed: 19526461
Front Cell Dev Biol. 2019 Jan 31;7:6
pubmed: 30766871
Eur J Cancer. 2011 Aug;47(12):1837-45
pubmed: 21621406
Cancers (Basel). 2013 May 24;5(2):591-616
pubmed: 24216993
Clin Sarcoma Res. 2013 Jul 23;3(1):10
pubmed: 23880362
Cancers (Basel). 2020 Feb 13;12(2):
pubmed: 32069980
Oncol Rev. 2016 Nov 14;10(2):309
pubmed: 27994771
Eur J Cell Biol. 2016 Nov;95(11):449-464
pubmed: 27397692
Nat Commun. 2013;4:2268
pubmed: 23917225
Nucleus. 2014 Sep-Oct;5(5):427-40
pubmed: 25482195
Oncotarget. 2015 May 30;6(15):13628-43
pubmed: 25909222
Cancer Med. 2015 Oct;4(10):1547-57
pubmed: 26175118
Biochem Cell Biol. 2019 Aug;97(4):463-470
pubmed: 30608867
Biochem Soc Trans. 2011 Dec;39(6):1698-704
pubmed: 22103510
Nat Med. 2004 Aug;10(8):789-99
pubmed: 15286780
Breast Cancer Res Treat. 2019 Apr;174(3):661-668
pubmed: 30610489
Mol Cancer Ther. 2018 Sep;17(9):1881-1892
pubmed: 29959201
Cell Transplant. 2013;22(4):701-9
pubmed: 23068312
PLoS One. 2017 Aug 14;12(8):e0183136
pubmed: 28806747
Nat Rev Drug Discov. 2007 Jul;6(7):541-55
pubmed: 17585331
Bioorg Med Chem. 2018 Nov 1;26(20):5547-5554
pubmed: 30309670
Cell Oncol (Dordr). 2016 Apr;39(2):161-74
pubmed: 26732077
J Biol Chem. 2008 Nov 7;283(45):30549-56
pubmed: 18757369
Biochem Biophys Res Commun. 2017 Jul 8;488(4):664-670
pubmed: 28237702
J Biol Chem. 2010 Jan 29;285(5):3487-98
pubmed: 19933576
Cell Biol Int. 2016 Jun;40(6):610-8
pubmed: 26992453
Biogerontology. 2018 Dec;19(6):579-602
pubmed: 29907918
Trends Cell Biol. 2014 Apr;24(4):247-56
pubmed: 24309562
J Exp Clin Cancer Res. 2019 Dec 26;38(1):503
pubmed: 31878963
Cell Death Differ. 2011 Aug;18(8):1305-15
pubmed: 21311568
Indian J Med Paediatr Oncol. 2017 Jan-Mar;38(1):33-43
pubmed: 28469335
PLoS One. 2017 Apr 19;12(4):e0175953
pubmed: 28422997
Int J Cancer. 1999 Feb 9;80(4):581-8
pubmed: 9935160
Int J Oncol. 2018 Apr;52(4):1285-1294
pubmed: 29532878
J Struct Biol. 2006 Aug;155(2):351-60
pubmed: 16697219
Cell Mol Biol Lett. 2013 Dec;18(4):595-611
pubmed: 24293108
Cell. 2012 Apr 27;149(3):565-77
pubmed: 22541428
Oncologist. 2004;9(4):422-41
pubmed: 15266096
J Clin Oncol. 2005 Jun 10;23(17):3940-7
pubmed: 15867203
Exp Cell Res. 2008 Feb 1;314(3):453-62
pubmed: 18093584
J Hematol Oncol. 2016 Oct 24;9(1):114
pubmed: 27776559
J Bone Miner Res. 2012 Jun;27(6):1322-34
pubmed: 22367914

Auteurs

Camilla Evangelisti (C)

CNR Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza" Unit of Bologna, 40136 Bologna, Italy.
IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Francesca Paganelli (F)

Department of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy.

Gaia Giuntini (G)

Department of Molecular and Development Medicine, Cellular and Molecular Physiology Unit, University of Siena, 53100 Siena, Italy.

Elisabetta Mattioli (E)

CNR Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza" Unit of Bologna, 40136 Bologna, Italy.
IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Alessandra Cappellini (A)

Department of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy.

Giulia Ramazzotti (G)

Department of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy.

Irene Faenza (I)

Department of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy.

Maria Cristina Maltarello (MC)

Laboratory of Musculoskeletal Cell Biology, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Alberto M Martelli (AM)

Department of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy.

Katia Scotlandi (K)

Experimental Oncology Laboratory, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Francesca Chiarini (F)

CNR Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza" Unit of Bologna, 40136 Bologna, Italy.
IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Giovanna Lattanzi (G)

CNR Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza" Unit of Bologna, 40136 Bologna, Italy.
IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH